Financial Daily from THE HINDU group of publications
Tuesday, Nov 09, 2004

News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Corporate - People


Alan Sheppard to head Dr Reddy's Europe generics business

Our Bureau

Hyderabad , Nov. 8

DR Reddy's Laboratories Ltd has announced that Mr Alan Sheppard has joined the company as Executive Vice-President and Head of Europe Generics, and Managing Director and Head of Dr Reddy's UK Ltd.

In a press release here on Monday, Dr Reddy's said Mr Sheppard would be responsible for the management of the company's generics business in Europe and would be based at the company's offices in UK.

Commenting on development, the Dr Reddy's Chief Executive Officer, Mr G.V. Prasad, said, "Alan Sheppard brings with him a wealth of experience, which includes commercial, general management, R&D, manufacturing and strategic planning across generics, ethical branded, OTC and vaccines. Dr Reddy's will leverage this experience in taking our business forward in Europe."

Mr Sheppard joins Dr Reddy's from Pliva, a leading European pharmaceutical company, where he was Vice-President for Global Corporate Strategy. He had previously been Vice-President, Western Europe, where he was responsible for establishing Pliva's business in the European Union. He also served as General Manager of Rhone-Poulenc Rorer (now Aventis); European marketing director for Medeva and held various positions with Institute Merieux, Smith Kline and Upjohn.

According to the release, Mr Sheppard has served on several UK Government Committees and has been along standing member of the Association of British Pharmaceutical Industry's Code of Practice Committee, which regulates the promotion of medicines.

More Stories on : People | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
K Sera Sera plans to raise Rs 100 cr — International film project on cards


GE sells 60% stake in BPO arm for $500 m
Petronet India to be sold by March
Festival freebies from car cos
NCCL bags Rs 302-cr orders
JB Chem launches new product
Conversion of MNC arm into public co — `Concept paper proposal needs to be modified'
How Deloitte tackled attrition among women
Titan revamps Europe operations — To focus only on 4 markets, to exit from 8
Essilor to acquire Vijay Vision
Excise sops lure pharma, FMCG firms to the hills
Birla group plans to set up 30 ready-mix concrete plants
Call for clarity in definition of promoter
`We hope to achieve Rs 1,200 cr turnover this year'
Jessop to diversify into shipbuilding
Dabhol revival package likely by next month
Orchid Chem eyes $1-b turnover
`Delayed resolution of Dabhol no impact on GE's plans for India'
Alan Sheppard to head Dr Reddy's Europe generics business



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright 2004, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line